4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-19-053060
CEO sold 150,000 shares at an average $40.15 ($6,022,749)
- CEO acquired 150,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2019-10-09 | Option exercise | +29,792 | $19.65 | $585,413 | 29,792 | D |
| DAVIS STEPHEN CEO | 2019-10-09 | Sale | −29,792 | $40.00 | $1,191,710 | 0 | D |
| DAVIS STEPHEN CEO | 2019-10-10 | Option exercise | +120,208 | $19.65 | $2,362,087 | 120,208 | D |
| DAVIS STEPHEN CEO | 2019-10-10 | Sale | −120,208 | $40.19 | $4,831,039 | 0 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2019-10-09 | Option exercise · Stock Option (Right to Buy) | −29,792 | 570,208 | D | ||
| DAVIS STEPHEN CEO | 2019-10-10 | Option exercise · Stock Option (Right to Buy) | −120,208 | 450,000 | D | ||
| Open-market sales · 150,000 sh · avg $40.15 · $6,022,749 | |||||||
Loading xslF345X03/doc4.xml…